← Eichor
Condition: Immunoglobulin A Nephropathy Igan Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Immunoglobulin A Nephropathy Igan

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Early Application of Budesonide Enteric-coated Capsules in the Treatment of Primary IgA Nephropathy.
Phase N/A · 1 location(s) · Chinese PLA General Hospital · NCT07585981Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
Phase 3 · 9 location(s) · Haisco Pharmaceutical Group Co., Ltd. · NCT07390123Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD
Phase 3 · 1 location(s) · Air Force Military Medical University, China · NCT05510323Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07010250Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial
NA · 1 location(s) · Botkin Hospital · NCT07056595A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT06952426A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Phase 3 · 251 location(s) · Biogen · NCT06935357A Study of SHR-2173 in Participants With Primary IgA Nephropathy
Phase 2 · 2 location(s) · Guangdong Hengrui Pharmaceutical Co., Ltd · NCT07354932Correlation of Microbiome and Metabonomics With IgA Nephropathy
Phase N/A · 5 location(s) · Guangdong Provincial People's Hospital · NCT05190848CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT07305116PS-002 for the Treatment of IgA Nephropathy in Adults
Phase 1/Phase 2 · 10 location(s) · Purespring Therapeutics Limited · NCT07182227Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary
Phase 3 · 6 location(s) · Novartis Pharmaceuticals · NCT07498335A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patient
Phase N/A · 1 location(s) · Sichuan Provincial People's Hospital · NCT06676007A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Phase 3 · 172 location(s) · Takeda · NCT06963827Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Phase 2 · 47 location(s) · Travere Therapeutics, Inc. · NCT05003986Raman Spectroscopy Diagnosis of Kidney Diseases
Phase N/A · 1 location(s) · Zunsong Wang · NCT06760845Study of WAL0921 in Patients With Glomerular Kidney Diseases
Phase 2 · 50 location(s) · Walden Biosciences · NCT06466135Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease
EARLY_Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT06792799Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
EARLY_Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT07507201A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
Phase 2 · 9 location(s) · Jade Biosciences, Inc. · NCT07541287Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Phase 3 · 21 location(s) · Novartis Pharmaceuticals · NCT06858319A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA Nephropathy
Phase 2 · 2 location(s) · Haisco Pharmaceutical Group Co., Ltd. · NCT07616700Study of the Link Between Complement Activation and IgA Nephropathy Severity
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT05234463Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
Phase 4 · 38 location(s) · Calliditas Therapeutics AB · NCT06712407Atacicept in Multiple Glomerular Diseases
Phase 2 · 1 location(s) · Vera Therapeutics, Inc. · NCT06983028Interest of Follicular Helper Lymphocytes / Regulatory Follicular Helper Lymphocytes Ratio in IgA Nephropathy
NA · 1 location(s) · Centre Hospitalier Universitaire de Besancon · NCT05791162A Study of MIL116 in Healthy Participants and Patients With IgA Nephropathy.
Phase 1/Phase 2 · 1 location(s) · Beijing Mabworks Biotech Co., Ltd. · NCT07375758A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects
Phase 1 · 1 location(s) · Hansoh BioMedical R&D Company · NCT05942625China Kidney Patient Trials Network
Phase N/A · 1 location(s) · George (Beijing) Clinical Research Co. Ltd. · NCT05036850Chinese Adults With Kidney Disease
Phase 2 · 9 location(s) · ADARx Pharmaceuticals, Inc. · NCT07522099
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.